Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Burd

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Life Science Alliance|July 2, 2021
UVB mutagenesis differs in <i>Nras</i>- and <i>Braf</i>-mutant mouse models of melanomaRobert L Bowman, Rebecca C Hennessey, Tirzah J Weiss, et al.
Pigment Cell & Melanoma Research|September 23, 2022
Cell-intrinsic melanin fails to protect melanocytes from ultraviolet-mutagenesis in the absence of epidermal melaninTirzah J Weiss, Emma R Crawford, Valentina Posada, et al.
Aging Cell|January 26, 2020
Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of miceMatthew J Yousefzadeh, Jing Zhao, Christina Bukata, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 26, 2021
Aging Phenotypes and Restoring Functional Deficits in Older Adults With Hematologic MalignancyAshley E Rosko, Sarah Wall, Robert Baiocchi, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
The Association of the Microbiome with Melanoma Tumor Response to Immune Checkpoint Inhibitor Treatment and Immune-Related Adverse Events (NCT05102773)Caroline Dravillas, Nyelia Williams, Marium Husain, et al.
Pigment Cell & Melanoma Research|March 18, 2014
Targeted next generation sequencing identifies clinically actionable mutations in patients with melanomaWilliam R Jeck, Joel Parker, Craig C Carson, et al.
Nature Communications|June 7, 2022
Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiationBrandon M Murphy, Elizabeth M Terrell, Venkat R Chirasani, et al.
Cancer Discovery|September 26, 2014
Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanomaChristin E Burd, Wenjin Liu, Minh V Huynh, et al.
Cancer Immunology Research|March 3, 2021
Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor ImmunityManali S Phadke, Zhihua Chen, Jiannong Li, et al.
Cancer Discovery|June 18, 2025
Tumor-associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint BlockersNo-Joon Song, Juan Xie, Kyeong Joo Jung, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Life Science Alliance|July 2, 2021
UVB mutagenesis differs in <i>Nras</i>- and <i>Braf</i>-mutant mouse models of melanomaRobert L Bowman, Rebecca C Hennessey, Tirzah J Weiss, et al.
Pigment Cell & Melanoma Research|September 23, 2022
Cell-intrinsic melanin fails to protect melanocytes from ultraviolet-mutagenesis in the absence of epidermal melaninTirzah J Weiss, Emma R Crawford, Valentina Posada, et al.
Aging Cell|January 26, 2020
Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of miceMatthew J Yousefzadeh, Jing Zhao, Christina Bukata, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 26, 2021
Aging Phenotypes and Restoring Functional Deficits in Older Adults With Hematologic MalignancyAshley E Rosko, Sarah Wall, Robert Baiocchi, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
The Association of the Microbiome with Melanoma Tumor Response to Immune Checkpoint Inhibitor Treatment and Immune-Related Adverse Events (NCT05102773)Caroline Dravillas, Nyelia Williams, Marium Husain, et al.
Pigment Cell & Melanoma Research|March 18, 2014
Targeted next generation sequencing identifies clinically actionable mutations in patients with melanomaWilliam R Jeck, Joel Parker, Craig C Carson, et al.
Nature Communications|June 7, 2022
Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiationBrandon M Murphy, Elizabeth M Terrell, Venkat R Chirasani, et al.
Cancer Discovery|September 26, 2014
Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanomaChristin E Burd, Wenjin Liu, Minh V Huynh, et al.
Cancer Immunology Research|March 3, 2021
Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor ImmunityManali S Phadke, Zhihua Chen, Jiannong Li, et al.
Cancer Discovery|June 18, 2025
Tumor-associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint BlockersNo-Joon Song, Juan Xie, Kyeong Joo Jung, et al.
Pageof 8